Phase I clinical study of TNX-801 in Kenya
-
Health & Sanitation
US firm says potential mpox and smallpox vaccine to be tested in Kenya shows promise
US-based biopharmaceutical company, Tonix Pharmaceuticals, has presented data demonstrating that TNX-801 protected animals from mpox and rabbitpox and was well…
Read More »